Texas Biomed — a San Antonio research institute — played a key role in the development of the antibody treatment that former President Donald ...
News
- Texas Biomed President Says It's Too Soon To Lift Pandemic Restrictions
- Edited Transcript of ONC.TO earnings conference call or presentation 5-Mar-21 1:30pm GMT
Q4 2020 Oncolytics Biotech Inc Earnings Call Calgary Mar 5, 2021 ... recent AWARE-1 update at the 2020 San Antonio Breast Cancer Symposium.
- Oncolytics Biotech® Reports Fourth Quarter and Full Year 2020 Financial Results and Operational ...
AWARE-1 data presented at the 2020 San Antonio Breast Cancer Symposium (SABCS) showed that systemic pelareorep treatment increased tumor ...
- NGM Biopharmaceuticals: Q4 Earnings Snapshot
The biotechnology company posted revenue of $19.8 million in the period, falling short of Street forecasts. Four analysts surveyed by Zacks expected ...
- Social distancing in nature
In a new review published in Science, Dana Hawley, a professor of biological sciences in the Virginia Tech College of Science and ... of Bristol, University of Texas at San Antonio, and University of Connecticut have highlighted just a ...